Drug Topics March 25, 2025
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, discusses recent advancements in diabetes care.
The diabetes management landscape has undergone significant transformations in recent years, with pharmacists playing a crucial role in understanding and implementing these changes, according to Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University. Metformin is no longer the first-line therapy for diabetes, a shift that occurred in October 2022. This change reflects a broader understanding that diabetes management extends far beyond glucose control, encompassing cardiovascular, kidney, liver, and cognitive health.
The emergence of GLP-1 agents and SGLT-2 inhibitors represents a major breakthrough in diabetes...
Today's Sponsors
Today's Sponsor